Aura Biosciences, Inc. logo

Aura Biosciences, Inc.

NASDAQ:AURA

Overview | Financials
Company Name Aura Biosciences, Inc.
Symbol AURA
Currency USD
Price 8.2
Market Cap 409,602,021
Dividend Yield 0%
52-week-range 6.63 - 12.378
Industry Biotechnology
Sector Healthcare
CEO Dr. Elisabet de los Pinos Ph.D.
Website https://www.aurabiosciences.com

An error occurred while fetching data.

About Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It

Related Stocks

Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc.

TNGX

3.1 USD

Geron Corporation logo

Geron Corporation

GERN

3.49 USD

Century Therapeutics, Inc. logo

Century Therapeutics, Inc.

IPSC

1.1 USD

Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

STOK

11.68 USD

Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc.

CRBU

1.8 USD

PetIQ, Inc. logo

PetIQ, Inc.

PETQ

30.98 USD

ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc.

ANIP

53.35 USD

GH Research PLC logo

GH Research PLC

GHRS

6.85 USD

Financials

Numbers are in millions USD

Numbers are in millions USD